Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The heart of the matter of opinion and evidence: the value of evidence-based medicine.

Literature DB >> 22438783

The heart of the matter of opinion and evidence: the value of evidence-based medicine.

Abstract

Evidence-based medicine is an important aspect of continuing medical education. This article reviews previous and current examples of conflicting topics that evidence-based medicine has clarified to allow us to provide the best possible patient care.

Entities: Species

Keywords: Continuing medical education; evidence-based medicine

Year: 2012 PMID： 22438783 PMCID： PMC3307507

Source DB: PubMed Journal: Ochsner J ISSN： 1524-5012

33 in total

1. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.

Authors: K G Losonczy; T B Harris; R J Havlik
Journal: Am J Clin Nutr Date: 1996-08 Impact factor: 7.045

2. The failure of torcetrapib: was it the molecule or the mechanism?

Authors: Alan R Tall; Laurent Yvan-Charvet; Nan Wang
Journal: Arterioscler Thromb Vasc Biol Date: 2007-02 Impact factor: 8.311

3. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

Authors: Emil M deGoma; Nicholas J Leeper; Paul A Heidenreich
Journal: J Am Coll Cardiol Date: 2008-01-01 Impact factor: 24.094

4. The philosophical limits of evidence-based medicine.

Authors: M R Tonelli
Journal: Acad Med Date: 1998-12 Impact factor: 6.893

5. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors:
Journal: JAMA Date: 2002 Oct 23-30 Impact factor: 56.272

6. Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors: Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal: N Engl J Med Date: 2007-03-26 Impact factor: 91.245

7. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors: S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal: JAMA Date: 1998-08-19 Impact factor: 56.272

The heart of the matter of opinion and evidence: the value of evidence-based medicine.

1. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.

2. The failure of torcetrapib: was it the molecule or the mechanism?

3. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

4. The philosophical limits of evidence-based medicine.

5. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

6. Effect of torcetrapib on the progression of coronary atherosclerosis.

7. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

8. Vitamin E consumption and the risk of coronary disease in women.

9. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.

10. Risk factors for sudden death after acute myocardial infarction: two-year follow-up.

1. Recent publications by ochsner authors.